{"id":814101,"date":"2025-02-18T08:34:55","date_gmt":"2025-02-18T13:34:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/"},"modified":"2025-02-18T08:34:55","modified_gmt":"2025-02-18T13:34:55","slug":"myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/","title":{"rendered":"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025"},"content":{"rendered":"<h2>\nManagement will participate in three upcoming investor healthcare conferences<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>SALT LAKE CITY, Feb.  18, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DXgUpVaPNqTtZIa_d0m4xg3bEFQ6X0i-11rqdIhxgmScX19Tfhb0g3CHEOy4guRmaqVFvZh59owCmqDWujWECQ==\" rel=\"nofollow\" target=\"_blank\">Myriad Genetics, Inc<\/a>. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, will hold its fourth quarter and full year 2024 earnings conference call at 4:30 pm ET on Monday, Feb. 24, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the fourth quarter and full year 2024.<\/p>\n<p>A live webcast of the earnings conference call can be accessed on Myriad\u2019s Investor Relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sCCx1iqxB7YoZQpduaMfKehY8_l7x8mOjxeNCaD4CFy2WReQwQKxFuOn98FbddtPvrDDrzYLkU-3kFYzdE6f-cqmfqRUlqZPassDX2OqaZY=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>. To participate in the live conference call via telephone, please register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vC_lF4X_IiYXxO3O3MnYM7FeHxlJufodcVwswKVOxqJThypJHqNeFnqaoXAMnb0JpITF9G601IRA6VebTyGikEFrOQnC_4tmw9NTUkRlsSwVIkRvERevI_e2S-1-i65eeN-GSy7dMHQpsA7rh1pbrg==\" rel=\"nofollow\" target=\"_blank\">here<\/a>. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sCCx1iqxB7YoZQpduaMfKYnlcKu8P9yefv0vJnCpbCRdUdU2Cz6W_meDp11dcHGEu90U0KCm-Xa0QwaM2VaXUqvAMTBo5C2uU2S5TL1F_ys=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a> following the call.<\/p>\n<p>\n        <strong>Upcoming Investor Conferences<\/strong><br \/>\n        <br \/>Management plans to participate in the following investor healthcare conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>The TD Cowen 45th Annual Health Care Conference<\/strong> \u2013 fireside chat at 9:50 am ET on Tuesday, March 4, 2025.<\/li>\n<li>\n          <strong>The Raymond James 46th Annual Institutional Investors Conference<\/strong> \u2013 formal presentation at 4:00 pm ET on Tuesday, March 4, 2025.<\/li>\n<li>\n          <strong>The Leerink Global Healthcare Conference<\/strong> \u2013 fireside chat at 2:20 pm ET on Monday, March 10, 2025.<\/li>\n<\/ul>\n<p>\n        <strong>About Myriad Genetics<\/strong><br \/>\n        <br \/>Myriad Genetics is a leading genetic and genomic tumor testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vWfH3xXBYKNQn7EGi-c09lpEUdl6XEmqywS2TsE7nNM_eeS0hhg6bOnRCzzrx-OlNgkdJ3X2Ht1UuZ-Z2wmHRA==\" rel=\"nofollow\" target=\"_blank\">www.myriad.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact\u00a0<\/strong><br \/>\n        <br \/>Matt Scalo\u00a0<br \/>(801) 584-3532\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zc12dgIPobMwxjLfqaj-jnmMBVo2onN0qkwm5TS9cqn-suIr-T8fAnlMURJ_mG5t7iIw91YouB3NJFMv6m_STQ==\" rel=\"nofollow\" target=\"_blank\"><u>IR@myriad.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact\u00a0<\/strong><br \/>\n        <br \/>Kate Schraml<br \/>(224) 875-4493<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZJGcwYIfQ4hi8EIqKCZMsDdYqLkxtoUB-hC7MhnYUJamEQ_LA2ZqNJUqIBcfYEPIWN1FQ7vLP-7cQyL1YHD4Og==\" rel=\"nofollow\" target=\"_blank\"><u>PR@myriad.com<\/u><\/a>\u00a0\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmNjODI2ZTktZTBjMC00MGFhLTkxNjctYzQ1NTFmMTA2ZDg1LTEwMTk0NjA=\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Management will participate in three upcoming investor healthcare conferences SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, will hold its fourth quarter and full year 2024 earnings conference call at 4:30 pm ET on Monday, Feb. 24, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the fourth quarter and full year 2024. A live webcast of the earnings conference call can be accessed on Myriad\u2019s Investor Relations website at investor.myriad.com. To participate in the live conference call via &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-814101","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Management will participate in three upcoming investor healthcare conferences SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, will hold its fourth quarter and full year 2024 earnings conference call at 4:30 pm ET on Monday, Feb. 24, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the fourth quarter and full year 2024. A live webcast of the earnings conference call can be accessed on Myriad\u2019s Investor Relations website at investor.myriad.com. To participate in the live conference call via &hellip; Continue reading &quot;Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T13:34:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025\",\"datePublished\":\"2025-02-18T13:34:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/\",\"name\":\"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=\",\"datePublished\":\"2025-02-18T13:34:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Market Newsdesk","og_description":"Management will participate in three upcoming investor healthcare conferences SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, will hold its fourth quarter and full year 2024 earnings conference call at 4:30 pm ET on Monday, Feb. 24, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the fourth quarter and full year 2024. A live webcast of the earnings conference call can be accessed on Myriad\u2019s Investor Relations website at investor.myriad.com. To participate in the live conference call via &hellip; Continue reading \"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-18T13:34:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025","datePublished":"2025-02-18T13:34:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/"},"wordCount":310,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/","name":"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=","datePublished":"2025-02-18T13:34:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTU5NyM2NzU0Mzk2IzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-february-24-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=814101"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814101\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=814101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=814101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=814101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}